ASCO-GI 2021: Ivosidenib Improves Outcomes in IDH1-Mutant Cholangiocarcinoma
Findings will be used to seek regulatory approval for ivosidenib for use in this new indication
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.